Tracking Major Hemorrhage Risk Factors in CLL Patients

by U.S. Medicine

June 26, 2019

COLUMBIA, SC—Understanding that chronic lymphocytic leukemia patients are at increased risk for major hemorrhage, a study published in Cancer Medicine examined incidence of and risk factors for MH in CLL patients before introduction of newer CLL therapies such as ibrutinib, which includes bleeding risk.

The study led by researchers from the William Jennings Bryan Dorn VAMC included more than 24,000 CLL patients treated in the VA system before FDA approval of ibrutinib as CLL therapy, with data pulled from VA databases from 1999 to 2013.

Results indicated that MH incidence was 1.9/100 person-years (95% CI: 1.8-1.9), with cumulative incidences of 2.3%, 5.2%, and 7.3% by Years 1, 3 and 5, respectively. The study team calculated that median time from CLL diagnosis to MH was 2.8 years (range: 0-15.7 years).

Increasing MH risk, according to multivariate analyses, were concurrent anticoagulant and antiplatelet use (HR: 4.2; 95% CI: 3.2-5.6), anticoagulant use only (HR: 2.6; 95% CI: 2.3-3.1), and antiplatelet use only (HR: 1.5; 95% CI: 1.3-1.7) vs. not receiving those medications. Other factors linked to greater major hemorrhage risk were being nonwhite, male, having MH history, renal impairment, anemia, thrombocytopenia and alcohol abuse.

“These pre-ibrutinib data are important for providing context for interpreting MH risk in ibrutinib-treated patients,” study authors wrote. “As ibrutinib clinical use is increasing, updated analyses of MH risk among ibrutinib-treated VA patients with CLL may provide additional useful insight.”


1 Georgantopoulos P, Yang H, Norris LB, Bennett CL. Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre-ibrutinib era: Incidence and risk factors. Cancer Med. 2019 Apr 14. doi: 10.1002/cam4.2134. [Epub ahead of print] PubMed PMID: 30983123.

Related Articles

Million Veteran Program Study Raises Questions about Omega-3 Benefits in CAD

BOSTON—Researchers at the Massachusetts Veterans Epidemiology and Research Information Center demonstrated the value of the VA’s ability to harness the health data of thousands or even millions of individuals in a study that calls into... View Article

Pharmacist Involvement Improves Accuracy of Direct Oral Anticoagulants

PALO ALTO, CA—For decades, patients prescribed warfarin to reduce the risk of stroke following a diagnosis of atrial fibrillation have made regular visits to pharmacist- or nurse-directed clinics to ensure their international normalized ratio (INR)... View Article

U.S. Medicine Recommends

More From hematology


Certain Hematologic Malignancies Increase Head/Neck Tumors

PORTLAND, OR—With more than 1.3 million people in the United States having been diagnosed with a hematologic malignant tumor currently or in remission, previous research has suggested an increased risk of secondary neoplasms. Yet, the... View Article


VA Study: Anemia Often Overlooked in IBD Patients

HOUSTON—Anemia is a common complication of inflammatory bowel disease, and existing guidelines urge vigilance for the condition. Yet, according to a study in Digestive Diseases & Sciences, it is frequently undertreated, resulting in the prevalence... View Article


VA Research Demonstrates Importance of Personalization in DLBCL Treatment

Diffuse large b-cell lymphoma accounts for approximately one-third of all cases of non-Hodgkin lymphoma, which is classified by the VA as a presumptive disease for veterans exposed to Agent Orange while serving in Vietnam.


Army Research Challenges Long-Standing Platelet Storage Recommendations

For nearly 50 years, platelets have been stored at room temperature. Research conducted by investigators at the U.S. Army Institute of Surgical Research Center in San Antonio very well could change that.

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up